114 related articles for article (PubMed ID: 7521273)
1. Expression of the estrogen receptor in human thyroid neoplasms.
Yane K; Kitahori Y; Konishi N; Okaichi K; Ohnishi T; Miyahara H; Matsunaga T; Lin JC; Hiasa Y
Cancer Lett; 1994 Aug; 84(1):59-66. PubMed ID: 7521273
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical study of epidermal growth factor receptor and estrogen receptor in human thyroid tumors].
Yane K; Tanaka O; Miyahara H; Matsunaga T; Kitahori Y; Hiasa Y
Nihon Jibiinkoka Gakkai Kaiho; 1993 May; 96(5):787-90. PubMed ID: 8315535
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and estrogen receptors in thyroid carcinomas.
Mizukami Y; Michigishi T; Nonomura A; Hashimoto T; Noguchi M; Matsubara F
J Surg Oncol; 1991 Jul; 47(3):165-9. PubMed ID: 2072699
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of estrogen receptors in 313 paraffin section cases of human thyroid tissue.
Hiasa Y; Nishioka H; Kitahori Y; Yane K; Nakaoka S; Ohshima M; Konishi N; Nishii K; Kitamura M; Matsunaga T
Oncology; 1993; 50(2):132-6. PubMed ID: 8451035
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.
Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H
Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and progesterone receptor detection in neoplastic and non-neoplastic thyroid tissues.
Bur M; Shiraki W; Masood S
Mod Pathol; 1993 Jul; 6(4):469-72. PubMed ID: 8415594
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in normal and malignant thyroid tissues by real-time polymerase chain reaction.
Egawa C; Miyoshi Y; Iwao K; Shiba E; Noguchi S
Oncology; 2001; 61(4):293-8. PubMed ID: 11721176
[TBL] [Abstract][Full Text] [Related]
8. Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in thyroid diseases: difference between neoplasms and hyperplastic lesions.
Shingu K; Fujimori M; Ito K; Hama Y; Kasuga Y; Kobayashi S; Itoh N; Amano J
Endocr J; 1998 Feb; 45(1):35-43. PubMed ID: 9625444
[TBL] [Abstract][Full Text] [Related]
9. [Estrogen receptors in the malignant and benign neoplasms of the thyroid].
Lewy-Trenda I
Pol Merkur Lekarski; 1998 Aug; 5(26):80-3. PubMed ID: 10101461
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors.
Martins L; Matsuo SE; Ebina KN; Kulcsar MA; Friguglietti CU; Kimura ET
J Clin Endocrinol Metab; 2002 Oct; 87(10):4806-10. PubMed ID: 12364477
[TBL] [Abstract][Full Text] [Related]
11. [Detection of estrogen receptor (ER) mRNA by use of reverse transcriptase-polymerase chain reaction (RT-PCR) assay; comparison with dextran coated charcoal (DCC) assay and immunocytochemical assay].
Ozaki T
Gan To Kagaku Ryoho; 1992 Mar; 19(3):361-6. PubMed ID: 1371912
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of sex hormones and expression of their receptors in thyroid tissue in female patients with various types of thyroid neoplasms.
Liu J; Chen G; Meng XY; Liu ZH; Dong S
Pathol Res Pract; 2014 Dec; 210(12):830-5. PubMed ID: 25305147
[TBL] [Abstract][Full Text] [Related]
13. Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method.
Ishizaka Y; Kobayashi S; Ushijima T; Hirohashi S; Sugimura T; Nagao M
Oncogene; 1991 Sep; 6(9):1667-72. PubMed ID: 1717926
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of estrogen receptors and the responsiveness to estrogen in papillary thyroid carcinoma.
Inoue H; Oshimo K; Miki H; Kawano M; Monden Y
Cancer; 1993 Aug; 72(4):1364-8. PubMed ID: 8339226
[TBL] [Abstract][Full Text] [Related]
15. Reduced nm 23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid.
Arai T; Watanabe M; Onodera M; Yamashita T; Masunaga A; Itoyama S; Itoh K; Sugawara I
Am J Pathol; 1993 Jun; 142(6):1938-44. PubMed ID: 8389529
[TBL] [Abstract][Full Text] [Related]
16. Potential for estrogen synthesis and action in human normal and neoplastic thyroid tissues.
Dalla Valle L; Ramina A; Vianello S; Fassina A; Belvedere P; Colombo L
J Clin Endocrinol Metab; 1998 Oct; 83(10):3702-9. PubMed ID: 9768687
[TBL] [Abstract][Full Text] [Related]
17. Establishment of estrogen receptor-positive transplantable rat thyroid tumor cell lines in vivo.
Hiasa Y; Kitahori Y; Yane K; Nishioka H; Nakahashi K; Konishi N; Ohshima M; Okaichi K; Ohnishi T; Lin JC
Cancer Res; 1993 Sep; 53(18):4408-12. PubMed ID: 8364936
[TBL] [Abstract][Full Text] [Related]
18. Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerate primers: specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma.
Takano T; Matsuzuka F; Sumizaki H; Kuma K; Amino N
Cancer Res; 1997 Sep; 57(17):3792-7. PubMed ID: 9288789
[TBL] [Abstract][Full Text] [Related]
19. Measurement of the expression of oncofetal fibronectin mRNA in thyroid carcinomas by competitive reverse transcription-polymerase chain reaction.
Higashiyama T; Takano T; Matsuzuka F; Liu G; Miyauchi A; Yokozawa T; Morita S; Kuma K; Shiba E; Noguchi S; Amino N
Thyroid; 1999 Mar; 9(3):235-40. PubMed ID: 10211598
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and progesterone receptor content in human thyroid disease.
van Hoeven KH; Menendez-Botet CJ; Strong EW; Huvos AG
Am J Clin Pathol; 1993 Feb; 99(2):175-81. PubMed ID: 8438791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
